Idarubicin vs doxorubicin in transarterial chemoembolization of intermediate stage hepatocellular carcinoma

BACKGROUND: Liver cancer is the fifth most common cancer and the second cause of cancer-related deaths worldwide. Transarterial chemoembolization (TACE) is the best treatment of intermediate hepatocellular carcinoma (HCC). Doxorubicin is the most commonly used drug despite a low level of evidence. A...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:World J Gastroenterol
Main Authors: Roth, Gaël Stéphane, Teyssier, Yann, Abousalihac, Mélodie, Seigneurin, Arnaud, Ghelfi, Julien, Sengel, Christian, Decaens, Thomas
Format: Artigo
Jezik:Inglês
Izdano: Baishideng Publishing Group Inc 2020
Teme:
Retrospective Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6969879/
https://ncbi.nlm.nih.gov/pubmed/31988592
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i3.324
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki